The global artificial pancreas device systems market is currently experiencing robust growth. APDS refers to a closed-loop or automated insulin delivery system that manages blood glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a subcutaneous insulin infusion pump and a controller that links the monitor with the pump. It runs a complex algorithm that determines the adequate levels of insulin and time of delivery based on the evaluation of real-time glucose readings. It is primarily used to minimize the risks of extreme fluctuations of glucose levels in the body.

The increasing prevalence of pancreatic cancer, pancreatitis and other chronic ailments is one of the key factors driving the growth of the market. Furthermore, the growing occurrence of diabetes and obesity, due to age-related factors, physical inactivity and unhealthy dietary patterns, is also contributing to the widespread adoption of APDS across the globe. The rising demand for efficient diabetes monitoring and minimally invasive (MI) drug delivery systems is also providing a boost to the market growth. APDS automatically monitors the glucose levels and administers doses of insulin throughout the day in controlled amounts. Various technological innovations, including the development of software-based wireless systems that are integrated with automated controls, are further contributing to the market growth. Moreover, regulatory bodies and governments of various nations are significantly investing in research and development (R&D) for the improvement of healthcare infrastructure across the globe. For instance, the Food and Drug Association (US FDA) in the United States is approving an increasing number of new and innovative products, which is creating a positive outlook for the market in the country. Looking forward, IMARC Group expects the market to exhibit a CAGR of around 18% during 2020-2025. 

Breakup by Device Type:

• Threshold Suspend Device Systems
• Control-to-Range Systems
• Control-to-Target Systems
   

Breakup by Treatment Type:

• Bi-hormonal
• Insulin Only
• Hybrid
   

Breakup by End-User:

• Hospitals
• Medical Centres
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Beta Bionics Inc., Bigfoot Biomedical Inc., Cellnovo Limited, Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic Inc., Roche Holding AG, Tandem Diabetes Care Inc., Typezero Technologies Inc., etc.

Key Questions Answered in This Report:

• How has the global artificial pancreas device systems market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What is the breakup of the market based on the device type?
• What is the breakup of the market based on the treatment type?
• What is the breakup of the market based on the end-user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global artificial pancreas device systems market and who are the key players?
• What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Artificial Pancreas Device Systems Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Forecast
6    Market Breakup by Device Type
    6.1    Threshold Suspend Device Systems
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Control- to-Range Systems
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Control-to-Target Systems
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Treatment Type
    7.1    Bi-hormonal
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Insulin Only
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Hybrid
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by End-User
    8.1    Hospital
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Medical Centres
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Indicators
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Beta Bionics Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
        14.3.2    Bigfoot Biomedical Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio 
        14.3.3    Cellnovo Limited 
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 Financials
        14.3.4    Dexcom Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Inreda Diabetic B.V.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 Financials
        14.3.6    Insulet Corporation
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Johnson & Johnson
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis 
        14.3.8    Medtronic Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio 
        14.3.9    Roche Holding AG
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 
           14.3.9.3 Financials
        14.3.10    Tandem Diabetes Care Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 Financials
 

List of Figures

Figure 1: Global: Artificial Pancreas Device System Market: Major Drivers and Challenges
Figure 2: Global: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014-2019
Figure 3: Global: Artificial Pancreas Device System Market: Breakup by Device Type (in %), 2019
Figure 4: Global: Artificial Pancreas Device System Market: Breakup by Treatment Type (in %), 2019
Figure 5: Global: Artificial Pancreas Device System Market: Breakup by End-User (in %), 2019
Figure 6: Global: Artificial Pancreas Device System Market: Breakup by Region (in %), 2019
Figure 7: Global: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 8: Global: Artificial Pancreas Device System (Threshold Suspend Device Systems) Market: Sales Value (in Million US$), 2014 & 2019
Figure 9: Global: Artificial Pancreas Device System (Threshold Suspend Device Systems) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 10: Global: Artificial Pancreas Device System (Control- to-Range Systems) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: Artificial Pancreas Device System (Control- to-Range Systems) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: Artificial Pancreas Device System (Control-to-Target Systems) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: Artificial Pancreas Device System (Control-to-Target systems) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: Artificial Pancreas Device System (Bi-hormonal) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: Artificial Pancreas Device System (Bi-hormonal) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: Artificial Pancreas Device System (Insulin Only) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: Artificial Pancreas Device System (Insulin Only) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 18: Global: Artificial Pancreas Device System (Hybrid) Market: Sales Value (in Million US$), 2014 & 2019
Figure 19: Global: Artificial Pancreas Device System (Hybrid) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: Artificial Pancreas Device System (Hospital) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: Artificial Pancreas Device System (Hospital) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 22: Global: Artificial Pancreas Device System (Medical Centres) Market: Sales Value (in Million US$), 2014 & 2019
Figure 23: Global: Artificial Pancreas Device System (Medical Centres) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 24: Global: Artificial Pancreas Device System (Other End-Users) Market: Sales Value (in Million US$), 2014 & 2019
Figure 25: Global: Artificial Pancreas Device System (Other End-Users) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 26: North America: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 27: North America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 28: United States: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 29: United States: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 30: Canada: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 31: Canada: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 32: Asia Pacific: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 33: Asia Pacific: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 34: China: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 35: China: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 36: Japan: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 37: Japan: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 38: India: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 39: India: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 40: South Korea: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 41: South Korea: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 42: Australia: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 43: Australia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 44: Indonesia: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 45: Indonesia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 46: Others: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 47: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 48: Europe: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 49: Europe: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 50: Germany: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 51: Germany: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 52: France: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 53: France: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 54: United Kingdom: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 55: United Kingdom: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 56: Italy: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 57: Italy: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 58: Spain: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 59: Spain: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 60: Russia: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 61: Russia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 62: Others: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 63: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 64: Latin America: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 65: Latin America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 66: Brazil: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 67: Brazil: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 68: Mexico: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 69: Mexico: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 70: Others: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 71: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 72: Middle East and Africa: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2014 & 2019
Figure 73: Middle East and Africa: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 74: Global: Artificial Pancreas Device System Industry: SWOT Analysis
Figure 75: Global: Artificial Pancreas Device System Industry: Value Chain Analysis
Figure 76: Global: Artificial Pancreas Device System Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Artificial Pancreas Device System Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Device Type (in Million US$), 2020-2025
Table 3: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Treatment Type (in Million US$), 2020-2025
Table 4: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by End-User (in Million US$), 2020-2025
Table 5: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 6: Global: Artificial Pancreas Device System Market: Competitive Structure
Table 7: Global: Artificial Pancreas Device System Market: Key Players